https://www.renbio.com/news_and_events/renbio-attended-bio-international-convention/
More News & Events
- RenBio attended BIO International Convention
- RenBio to attend BIO in Boston, 5-8 June
- RenBio attends the Keystone Symposia on “Next Generation Antibody Therapeutics: From Discovery to Patient”
- RenBio presents at international electroporation conference
- RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications
- BioWorld reviews the nucleic acid-based antibody delivery field, including RenBio’s MYO Technology
- Biotech Company RenBio Moves to 7K SF in Long Island City
- RenBio’s Director of R&D, Rachel Liberatore, participates as panelist in NIH Summit on Anti-SARS-CoV-2 Antibodies
- RenBio completes $24M Series A Financing
- RenBio Scientists and Co-founders review the state of DNA-based antiviral antibody delivery, particularly for the prevention of infectious disease
- RenBio’s COO, Neal Padte, presents on “Antibody Gene Transfer by In Vivo Electroporation” at the “3rd World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies.”
- RenBio featured in Nature OUTLOOK: The genetic shortcut to antibody drugs
- RenBio’s DARPA-funded “Immunity on Demand” technology highlighted at Biotech Startups of the Future meeting
2023
2022
2021
2020
2019
2018
2017